Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes - TRILOGY ACS

Description:

The goal of the trial was to evaluate treatment with prasugrel compared with clopidogrel among patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) selected for medical management without revascularization.